article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

Exploring the available research on ALS and cannabinoids. The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94
article thumbnail

Mondaq-Dentons(UK)European Union: Will Medical Cannabis Soon Be Part Of The European Single Market?

Cannabis Law Report

In this resolution, the European Commission and the member states are urged to work on the legal framework of, and the research into, the use of cannabis for medicinal purposes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Does Cannabis Legalization Look Like in the UK?

Veriheal

Amphetamines, barbiturates, cannabis, codeine, ketamine, methylphenidate (Ritalin), synthetic cannabinoids, synthetic cathinones (for example mephedrone, methoxetamine). The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy.

article thumbnail

The ‘Father of Cannabis Research’ Leaves a Lasting Legacy Aged 97

Veriheal

Among his many contributions was the first ever isolation of tetrahydrocannabinol (THC) — cannabis’ primary psychoactive cannabinoid. I believe cannabinoids represent a medical treasure waiting to be discovered,” is one of his most famous (and still relevant) quotes.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC).

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.